Consistent with our data, the TCGA database revealed that patients with high DEPDC1B‐expressing PCa had significantly shorter OS, BCR‐free survival, and DFS times (Figure 1N‐P). This evidence concerns the gene DEPDC1B and posterior cortical atrophy.